Drug Name:
SOMINEX OTC
Generic Name and Formulations:
Diphenhydramine HCl 25mg; tabs.
Company:
GlaxoSmithKline
Therapeutic Use:
Indications for SOMINEX:
Short-term (≤ 2 weeks) treatment of insomnia.
Adult:
50mg at bedtime.
Children:
Not recommended.
Warnings/Precautions:
Asthma. Lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Pregnancy. Nursing mothers.
See Also:
Pharmacological Class:
Hypnotic (anticholinergic).
Interactions:
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant diphenhydramine products (including topicals): not recommended. Additive effects with other other anticholinergics.
Adverse Reactions:
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement.
How Supplied:
Original (tabs)—16, 32, 72
Max Strength (caplets)—16
Clinical Pain Advisor Articles
- MRS May Accurately Identify Painful Disks in Chronic Low Back Pain
- Examining the Relationships Among Opioid Use, Overdose, and Suicide
- Multispecies Probiotics May Be Effective in Chronic, Episodic Migraine
- Generalized Mechanical Hyperalgesia in Chronic Migraine, Temporomandibular Disorder
- Migraine Symptoms Can Improve Despite Unchanged Pain Avoidance, Endurance
- MRS May Accurately Identify Painful Disks in Chronic Low Back Pain
- Does Opioid Tapering in Chronic Pain Result in Controlled Pain at Taper Completion?
- Spinal Cord Stimulation Shows Long-Term Effectiveness for Refractory Neuropathic Pain
- Color Doppler Ultrasound for the Diagnosis of Sacroiliitis in Inflammatory Back Pain
- An Evidence-Based Road Map to Navigating the Opioid Epidemic
- Headache Frequency, Medication Overuse, and Depression Linked to Migraine
- Giving the Choice of Medical Support During Painful Procedures to Children With Cancer
- Mechanisms of Posttraumatic Headache
- Parents Conflicted About Opioid Use in Children
- Generalized Mechanical Hyperalgesia in Chronic Migraine, Temporomandibular Disorder
